Dr. Leonard Vidal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Hunter Holmes McGuire VA Medical Center
1201 Broad Rock Boulevard
Richmond, VA 23249Phone+1 804-675-5112Fax+1 804-675-5390
Education & Training
- University of MichiganFellowship, Surgical Critical Care, 2006 - 2007
- Henry Ford Health/Henry Ford HospitalChief Residency, Surgery, 2004 - 2006
- Virginia Commonwealth University Health SystemPost-Doctoral Fellowship, Abdominal Transplant Surgery, 2002 - 2004
- Beth Israel Deaconess Medical CenterResidency, Surgery, 1994 - 1995
- Massachusetts General HospitalResidency, Surgery, 1990 - 1993
- Brigham and Women's HospitalResidency, Complex General Surgical Oncology, 1988 - 1990
- Universidiad Francisco Marroquin Faculty of MedicineClass of 1987
- Universidad del Valle de GuatemalaB.S., 1982
Certifications & Licensure
- MI State Medical License 2006 - 2020
Awards, Honors, & Recognition
- Dean's Award for Best Medical Thesis 1998
- Dr. Fernando Biguria Scholarship 1989
- Best Average for Rotating Intern 1985
Publications & Presentations
Journal Articles
- Prostaglandin E2 Stimulates Hepatocyte Amino Acid Transport by Activating Protein Kinase CLeonard-Vidal FJ, Bode BP, Souba WW, 14th Annual Meeting of the Surgical Infection Society, 1/1/1994
- ln Vivo Efficacy of Murine Tumor-infiltrating Lymphocytes (TIL) Reactivated by Anti-CD3Zuber M, Leonard-Vidal FJ, Rubinstein AL, Massaro AF, Chang M, Schoof DD, Eberlein TJ, Journal of Cancer Research and Clinical Oncology, 1/1/1991
- Adoptive lmmunotherapy Utilizing Interleukin-2: An Altemative ApproachEberlein TJ, Mlchie HR, Massaro AF, Wilmore DW, Leonard-Vidal FJ, Schoof' DD, The Summer Trust Conference: Monoclonal Antibodies and lmmunoconjugates in Cancer Treatment, 1/1/1989
- Join now to see all
Abstracts/Posters
- Solid phase anti-CD3 antibody activation of murine tumor-infiltrating lymphocytes.Massaro AF, Schoof DD, Rubinstein Leonard-Vidal FJ, Zuber M, Eberlein TJ, Annual Cancer Symposium of S.S.O., Cancer Research, San Francisco, CA, 1/1/1990
Lectures
- Short term activation of murine tumor infiltrates (TIL): Pulmonary metastases reducingSweden - 1/1/1991
- Short-Term Activation of Murine Tumor infiltrating Lymphocytes (TIL): Pulmonary Metastases Reducing EfficacySalzburg, Austria - 1/1/1991
- Murine Tumor-infiltrating Lymphocytes: Reactivation by Solid-Phase Anti-CD3 on ln Vivo Efficacy.San Servolo Island, Venice, Italy, 1990; University of Basel, Switzerland, 1990 - 1/1/1990
- Join now to see all
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: